{"id":"W4286510751","doi":"10.1016/j.clgc.2022.07.008","title":"CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)","year":2022,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of Calgary; Alberta Cancer Foundation","funders":"Ipsen; Ipsen Biopharmaceuticals","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Refractory (planetary science); Oncology; Internal medicine; Carcinoma; Clear cell; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001331886,0.0004843498,0.0008977653,0.0001214729,0.0002398049,0.00001964012,0.0005994361,0.00007693594,0.0002581272],"category_scores_gemma":[0.0001832485,0.0002754882,0.0003561408,0.0003834359,0.0003793199,0.0001207775,0.0004331424,0.0008572198,0.000009842386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009365807,"about_ca_system_score_gemma":0.001114804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003235385,"about_ca_topic_score_gemma":0.000225084,"domain_scores_codex":[0.9942073,0.001874435,0.001340379,0.001028139,0.001065255,0.0004844735],"domain_scores_gemma":[0.9933016,0.004069498,0.0007708913,0.001361368,0.0002725941,0.0002241014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08063659,0.006669602,0.9001582,0.0001042192,0.0004362575,0.001393612,0.0006124624,0.001872899,0.003845554,0.000004300886,0.001448818,0.002817484],"study_design_scores_gemma":[0.03639565,0.007232974,0.9356737,0.000106008,0.0007442751,0.00001372901,0.0004621768,0.0001054788,0.01427075,0.00001158417,0.004689618,0.0002941068],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896395,0.001932088,0.000004898646,0.0005275503,0.0008621219,0.002202702,0.003621154,0.00002142712,0.001188528],"genre_scores_gemma":[0.9957039,0.0001454529,0.0002933893,0.0002858068,0.0003256053,0.000722126,0.001859063,0.00006788635,0.0005967862],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04424094,"threshold_uncertainty_score":0.9999697,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04049850419872496,"score_gpt":0.3156316967992041,"score_spread":0.2751331926004791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}